Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Chinese Journal of Medical Science Research Management ; (4): 284-291, 2021.
Article in Chinese | WPRIM | ID: wpr-912612

ABSTRACT

Objective:This study analyzes COVID-19 prevention and treatment technology patents from 103 countries and regions worldwide, in order to have a good grasp of the most-current trends in COVID-19 prevention and treatment technology research worldwide, discuss the research directions of such technologies, provide theoretical foundations for interdisciplinary and multi-team cooperation.Methods:The retrieval strategies were constructed utilizing the retrieval and analysis system by the Regional Patent Information Service (Nanjing) Center of The State Intellectual Property Office and IncoPat's scientific and technological innovation platform, using third-level branches as the unit and separating the retrieval and proof processes, the queries built using IPC classification numbers and key words; the search was limited to invention patents, with utility models and designs excluded.Results:On February 14, 2020, there had been a total number of 136 087 invention patent applications for COVID-19 prevention and treatment technologies globally. In terms of the country of origin, the U. S. ranked first with 56 095 patents, followed by China (18 096). In terms of technical field, the top three were chemical therapeutic agents (47 634), vaccines (47 248) and diagnostic tests (12 991), with the U. S. possessing absolutely advantageous patent portfolios in all three fields. The applicants were mainly comprised of large enterprises abroad and universities and research institutes in China.Conclusions:China′s COVID-19 related patent applications are relatively scattered. In the field of chemotherapy, there is room for improvement compared with the advanced countries, and cooperation between scientific institutions and enterprises is insufficient. Therefore, China should further increase investment in chemical drug research and development and seize the opportunity to actively promote the research and development of vaccine technology. On the other hand, we need to consolidate the technical advantages and product advantages of epidemic prevention and control which are already accumulated, and strengthen the protection and layout of intellectual property rights. Furthermore, the technological innovation system combining production, education and research is the breakthrough point to encourage enterprises to become the subject of technological innovation.Last but not least, we should build a service platform for the transfer and transformation of scientific and technological achievements to enhance intellectual property rights and promote the transformation of scientific and technological achievements.

2.
Rev. cub. inf. cienc. salud ; 31(3): e1589, fig
Article in Spanish | LILACS, CUMED | ID: biblio-1138861

ABSTRACT

El recurso más finito de un científico hoy es el tiempo. Un minuto sin una vacuna específica, un tratamiento adecuado o un protocolo seguro significa miles de muertes. A partir de esta necesidad, la presente investigación tuvo como objetivo caracterizar las funcionalidades del Observatorio Métrico de Coronavirus desarrollado por la Universidad de Pinar del Río Hermanos Saíz Montes de Oca como herramienta para el monitoreo, la compilación, el análisis y la visualización de la información procedente de artículos científicos arbitrados y de patentes de invención registradas en bases de datos internacionales sobre Coronavirus. Para su desarrollo se utilizaron diferentes métodos y procedimientos que permitieron, de conjunto con la tecnología aplicada y los indicadores métricos definidos, disponer de una plataforma dinámica que reduce significativamente los tiempos de búsqueda e interpretación de la información relevante sobre el dominio científico y tecnológico Coronavirus, lo que supone ser también un aporte oportuno y valioso que contribuye a la búsqueda de soluciones ante esta letal pandemia. Este Observatorio es un espacio de transformación de la información en conocimiento para la acción investigativa y la toma de decisiones. Es un resultado científico que contribuye al encadenamiento de la Academia con el sector investigativo y productivo de la Biotecnología en el país, conducido por los intereses y prioridades del Gobierno al servicio de toda la sociedad cubana(AU)


The finest resource for a scientist today is time. One minute without a specific vaccine, proper treatment, or a safe protocol means thousands of deaths. Based on this need, this research aims to show the functionalities of the Coronavirus Metric Observatory developed by the Pinar del Río University Hermanos Saíz Montes de Oca as a tool that allows the monitoring, compilation, analysis and visualization of information from peer-reviewed scientific papers and invention patents registered in international databases on Coronavirus. For its development, different methods and procedures were used that, together with the applied technology and the defined metric indicators, made it possible to have a dynamic platform that significantly reduces the search and interpretation times for relevant information on the scientific and technological domain Coronavirus. Having a dynamic platform that significantly reduces the time for analysis and interpretation of relevant information is also a timely and valuable contribution that contributes to the search for solutions to this deadly pandemic. This Observatory is a space for transforming information into knowledge for action. It is a scientific result that contributes to linking the Academy with the research and productive sector of Biotechnology in the country, driven by the interests and priorities of the Government at the service of all Cuban society(AU)


Subject(s)
Humans , Biotechnology , Coronavirus , Knowledge , Metric System/standards , Cuba
3.
China Pharmacy ; (12): 2177-2184, 2020.
Article in Chinese | WPRIM | ID: wpr-825644

ABSTRACT

OBJECTIVE:To provide reference for the R&D of TCM patents for treating gastric cancer and layout. METHODS:TCM patents for treating gastric cancer collected by the State Intellectual Property Office and the European Patent Office Espacenet were retrieved from the inception to Dec. 31st, 2019. After the initial examination ,a second search was conducted based on the keywords such as “Stomachache”“Fuliang” “Accumulation”“Cancer of stomach ”“Gastric”and their synonyms. Each literature was read one by one and screened manually. Excel 2007 software was used to input general information of included patents. SPSS modeler 15.0 software and SPSS 22.0 software were used for association rule analysis and hierarchical cluster analysis of TCM used more than 30 times and top 30 frequently used. Based on patent analysis ,internal strength (S),weakness(W),external opportunity (O)and threat (T)of TCM for treating gastric cancer were analyzed ;based on this ,four different types of combination strategies were formulated. RESULTS & CONCLUSIONS :Finally,385 patents were obtained ,including 379 domestic patents (98.44%) and 6 foreign patents (1.56%). The number of patent applications and applicants of TCM for treating gastric cancer in China was on the rise during 1994-2016. The commonly used TCM for treating gastric cancer were mainly tonifying deficiency drugs and heat clearing drugs , and the meridian tropism were mostly the stomach meridian and spleen meridian. According to the efficacy ,the commonly used drug combinations include the combination of tonifying spleen and Qi ,the combination of anti-cancer and detoxification ,and the combination of drying dampness and resolving phlegm. The results of hierarchical cluster analysis showed that Poria cocos , Atractylodes macrocephala ,Astragalus membranaceus ,Scutellaria barbata ,Hedyotis diffusa and Glycyrrhiza uralensis were clustered into one category and the common combination for treating gastric cancer. The remaining cluster distributions are also in line with the characteristics of TCM syndrome differentiation and treatment. Strength of domestic TCM patents for treating gastric cancer were that the number of patents in China was taking a leading position in the world ,the patent system of key applicants was mature,the combination of compound patents embodied the characteristics of disease and dialectical theory. Weakness included low patent authorization rate ,to-be-improved effectiveness and safety studies of TCM patents ,weak development of TCM extract patents,low degree of patent internationalization and hanging same-family patents. Opportunities were that the demand for drugs for gastric cancer was increasing with each passing day ,and natione actively support the development of the TCM industry. Threats were that competitors in the international market had the potential to seize the market. The development of TCM for treating gastric cancer in China should take market demand and national policy support as an opportunity ,learn from TCM patent characteristic system of key applicants ,continue to give full play to the advantages of TCM in prevention and syndrome differentiation of disease,pay more efforts to the development of weak links such as TCM extracts ,safety and effectiveness ,improve the international competitiveness in the field of patents ,while establish a warning and navigation analysis system for patents to effectively reduce the intellectual property threats and risks of invention patents of China in the international environment.

SELECTION OF CITATIONS
SEARCH DETAIL